# Gloo Holdings, Inc.: financial statements, quarterly

GLOO · Nasdaq · CIK 2069785 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/gloo.md) · [Financials](/companies/gloo/financials.md) · [Filings](/companies/gloo/filings.md) · [Insiders](/companies/gloo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gloo/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-04-30) | period not labelled (2024-07-31) | period not labelled (2024-10-31) | period not labelled (2025-01-31) | period not labelled (2025-04-30) | period not labelled (2025-07-31) | Q3 FY2025 (2025-10-31) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [6.1](/filings/0001193125-25-330952.md) | [6.5 d](/filings/0001193125-26-156999.md) | [12.3](/filings/0001193125-26-263889.md) | [16.2](/filings/0002069785-26-000003.md) | [32.6](/filings/0001193125-25-330952.md) | [33.6 d](/filings/0001193125-26-156999.md) | [41.5](/filings/0001193125-26-263889.md) | [46.6](/filings/0002069785-26-000003.md) |
| Operating income | $m | not reported | not reported | [(12.7)](/filings/0001193125-25-330952.md) | [(43.7) d](/filings/0001193125-26-156999.md) | [(22.1)](/filings/0001193125-26-263889.md) | [(24.4)](/filings/0002069785-26-000003.md) | [(26.7)](/filings/0001193125-25-330952.md) | [(35.0) d](/filings/0001193125-26-156999.md) | [(18.7)](/filings/0001193125-26-263889.md) | [(20.5)](/filings/0002069785-26-000003.md) |
| Interest expense | $m | not reported | not reported | [1.8](/filings/0001193125-25-330952.md) | [1.9 d](/filings/0001193125-26-156999.md) | [2.8](/filings/0001193125-26-263889.md) | [3.3](/filings/0002069785-26-000003.md) | [6.4](/filings/0001193125-25-330952.md) | [2.0 d](/filings/0001193125-26-156999.md) | [1.0](/filings/0001193125-26-263889.md) | [0.8](/filings/0002069785-26-000003.md) |
| Income tax | $m | not reported | not reported | [(0.1)](/filings/0001193125-25-330952.md) | [(0.2) d](/filings/0001193125-26-156999.md) | [0.0](/filings/0001193125-26-263889.md) | [(0.3)](/filings/0002069785-26-000003.md) | [(0.0)](/filings/0001193125-25-330952.md) | [0.7 d](/filings/0001193125-26-156999.md) | [(0.8)](/filings/0001193125-26-263889.md) | [(0.5)](/filings/0002069785-26-000003.md) |
| Net income | $m | [(14.2)](/filings/0001193125-25-330952.md) | [(13.2)](/filings/0001193125-25-330952.md) | [(13.6)](/filings/0001193125-25-330952.md) | [(44.7) d](/filings/0001193125-26-156999.md) | [(26.4)](/filings/0002069785-26-000003.md) | [(43.3)](/filings/0002069785-26-000003.md) | [(38.0)](/filings/0001193125-25-330952.md) | [(49.3) d](/filings/0001193125-26-156999.md) | [(16.8)](/filings/0002069785-26-000003.md) | [(21.3)](/filings/0002069785-26-000003.md) |
| Diluted EPS | $ per share | not reported | not reported | [(2.41)](/filings/0001193125-25-330952.md) | not reported | [(3.87)](/filings/0001193125-26-263889.md) | [(6.45)](/filings/0002069785-26-000003.md) | [(6.08)](/filings/0001193125-25-330952.md) | not reported | [(0.21)](/filings/0001193125-26-263889.md) | [(0.25)](/filings/0002069785-26-000003.md) |
| Basic EPS | $ per share | not reported | not reported | [(2.41)](/filings/0001193125-25-330952.md) | not reported | [(3.87)](/filings/0001193125-26-263889.md) | [(6.45)](/filings/0002069785-26-000003.md) | [(6.08)](/filings/0001193125-25-330952.md) | not reported | [(0.21)](/filings/0001193125-26-263889.md) | [(0.25)](/filings/0002069785-26-000003.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-01-31) | period not labelled (2024-01-31) | period not labelled (2024-04-30) | period not labelled (2024-07-31) | period not labelled (2024-10-31) | period not labelled (2025-01-31) | period not labelled (2025-04-30) | period not labelled (2025-07-31) | Q3 FY2025 (2025-10-31) | FY2025 (2026-01-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | [13.6](/filings/0001193125-26-156999.md) | not reported | not reported | [15.1](/filings/0001193125-25-330952.md) | [57.3](/filings/0002069785-26-000003.md) | [33.0](/filings/0001193125-26-263889.md) | [39.3](/filings/0002069785-26-000003.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | [18.3](/filings/0001193125-26-156999.md) | not reported | not reported | [39.0](/filings/0001193125-25-330952.md) | [75.6](/filings/0002069785-26-000003.md) | [50.5](/filings/0001193125-26-263889.md) | [67.5](/filings/0002069785-26-000003.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | not reported | [121](/filings/0001193125-26-156999.md) | not reported | not reported | [207](/filings/0001193125-25-330952.md) | [264](/filings/0002069785-26-000003.md) | [239](/filings/0001193125-26-263889.md) | [271](/filings/0002069785-26-000003.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | [20.6](/filings/0001193125-26-156999.md) | not reported | not reported | [47.4](/filings/0001193125-25-330952.md) | [48.5](/filings/0002069785-26-000003.md) | [53.9](/filings/0001193125-26-263889.md) | [55.0](/filings/0002069785-26-000003.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | [107](/filings/0001193125-26-156999.md) | not reported | not reported | [265](/filings/0001193125-25-330952.md) | [106](/filings/0002069785-26-000003.md) | [94.6](/filings/0001193125-26-263889.md) | [112](/filings/0002069785-26-000003.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [67.0](/filings/0001193125-26-156999.md) | not reported | not reported | [163](/filings/0001193125-25-330952.md) | [29.5](/filings/0002069785-26-000003.md) | [16.0](/filings/0001193125-26-263889.md) | [32.3](/filings/0002069785-26-000003.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [3.2](/filings/0001193125-26-156999.md) | not reported | not reported | [7.2](/filings/0001193125-25-330952.md) | [5.8](/filings/0002069785-26-000003.md) | [17.8](/filings/0001193125-26-263889.md) | [5.1](/filings/0002069785-26-000003.md) |
| Shareholders' equity | $m | [(229)](/filings/0001193125-26-156999.md) | [(268)](/filings/0001193125-26-156999.md) | [(281)](/filings/0001193125-25-330952.md) | [(293)](/filings/0001193125-25-330952.md) | [(302)](/filings/0001193125-25-330952.md) | [(345)](/filings/0001193125-26-156999.md) | [(354)](/filings/0002069785-26-000003.md) | [(382)](/filings/0002069785-26-000003.md) | [(444)](/filings/0001193125-25-330952.md) | [135](/filings/0002069785-26-000003.md) | [122](/filings/0001193125-26-263889.md) | [137](/filings/0002069785-26-000003.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-01-31) | period not labelled (2025-04-30) | period not labelled (2025-07-31) | Q3 FY2025 (2025-10-31) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(12.9) d](/filings/0001193125-26-156999.md) | [(21.2)](/filings/0001193125-26-263889.md) | [(23.1) d](/filings/0002069785-26-000003.md) | [(18.7) d](/filings/0001193125-25-330952.md) | [(17.5) d](/filings/0001193125-26-156999.md) | [(17.1)](/filings/0001193125-26-263889.md) | [(10.9) d](/filings/0002069785-26-000003.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001193125-26-156999.md) | [0.3](/filings/0001193125-26-263889.md) | [0.2 d](/filings/0002069785-26-000003.md) | [(0.1) d](/filings/0001193125-25-330952.md) | [0.7 d](/filings/0001193125-26-156999.md) | [0.9](/filings/0001193125-26-263889.md) | [0.5 d](/filings/0002069785-26-000003.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-10-31) | period not labelled (2025-04-30) | period not labelled (2025-07-31) | Q3 FY2025 (2025-10-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7.8](/filings/0001193125-25-330952.md) | [8.2](/filings/0001193125-26-263889.md) | [8.2](/filings/0002069785-26-000003.md) | [8.3](/filings/0001193125-25-330952.md) | [80.8](/filings/0001193125-26-263889.md) | [84.1](/filings/0002069785-26-000003.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.